Company page
Sk Bioscience Co.,ltd.
Sk Bioscience Co., Ltd. is a public company traded under the ticker 302440 on the Korean market. The company has a market capitalization of approximately 1.997 billion USD. Sk Bioscience focuses on biopharmaceuticals, contributing to advancements in vaccine development and production.
- Ticker
- 302440:KRX
- Asset type
- Stock
- Market cap
- $2.00B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- KRX
- Currency
- KRW